Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Expert Review of Vaccines|March 19, 2013
Prostate cancer vaccinesAgnieszka Michael, Kate Relph, Nicola Annels, et al.Methods in Molecular Biology (Clifton, N.J.)|September 6, 2019
Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 Virus: Using a Bladder Tumor Precision-Cut Slice Model System to Assess Viral EfficacyKate Relph, Nicola Annels, Chris Smith, et al.Methods in Molecular Biology (Clifton, N.J.)|July 6, 2023
Analysis of ICAM-1 Expression on Bladder Carcinoma Cell Lines and Infectivity and Oncolysis by Coxsackie Virus A21Kate Relph, Mehreen Arif, Hardev Pandha, et al.Applied Immunohistochemistry & Molecular Morphology : AIMM|November 18, 2015
Immunohistochemistry Biomarkers in Nonmuscle Invasive Bladder CancerAlana D Ranzi, Jéssica N L da Silva, Túlio M Graziottin, et al.Expert Review of Gastroenterology & Hepatology|November 22, 2024
Implications of the microbiome after pancreatic cancer resection with regard to morbidity and mortalityNabeel Merali, Tarak Chouari, Su Junjun, et al.Cancers|September 9, 2023
Advances in Immunotherapeutics in Pancreatic Ductal AdenocarcinomaTarak Chouari, Francesca Soraya La Costa, Nabeel Merali, et al.BMC Cancer|October 5, 2018
Engrailed-2 (EN2) - a novel biomarker in epithelial ovarian cancerSophie Elena McGrath, Nicola Annels, Thumuluru K Madhuri, et al.Expert Review of Molecular Diagnostics|August 21, 2023
Cancer cell-derived extracellular vesicles activate hepatic stellate cells in colorectal cancerBhavik Y Patel, Rahul Bhome, Daniel S K Liu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2011
Engrailed-2 (EN2): a tumor specific urinary biomarker for the early diagnosis of prostate cancerRichard Morgan, Angela Boxall, Aagna Bhatt, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 17, 2024
A randomized phase II trial to examine modified vaccinia Ankara-5T4 vaccine in patients with relapsed asymptomatic ovarian cancer (TRIOC)Agnieszka Michael, William Wilson, Sunny Sunshine, et al.Pageof 2